T0	KEYPHRASE-NOTYPES 0 18	Cranial neuropathy
T1	KEYPHRASE-NOTYPES 31 67	frequent objective neurological sign
T2	KEYPHRASE-NOTYPES 71 92	Lyme neuroborreliosis
T3	KEYPHRASE-NOTYPES 126 134	patients
T4	KEYPHRASE-NOTYPES 140 170	early neurological involvement
T5	KEYPHRASE-NOTYPES 212 216	lato
T6	KEYPHRASE-NOTYPES 233 247	cranial nerves
T7	KEYPHRASE-NOTYPES 249 269	facial nerve paresis
T8	KEYPHRASE-NOTYPES 282 302	common manifestation
T9	KEYPHRASE-NOTYPES 306 315	infection
T10	KEYPHRASE-NOTYPES 331 353	bilateral facial palsy
T11	KEYPHRASE-NOTYPES 387 395	patients
T12	KEYPHRASE-NOTYPES 401 424	cranial nerve affection
T13	KEYPHRASE-NOTYPES 435 464	previous Scandinavian studies
T14	KEYPHRASE-NOTYPES 468 476	patients
T15	KEYPHRASE-NOTYPES 482 503	Lyme neuroborreliosis
T16	KEYPHRASE-NOTYPES 505 517	facial palsy
T17	KEYPHRASE-NOTYPES 545 550	cases
T18	KEYPHRASE-NOTYPES 558 597	Lyme disease-associated facial weakness
T19	KEYPHRASE-NOTYPES 616 621	onset
T20	KEYPHRASE-NOTYPES 655 686	painful meningoradiculoneuritis
T21	KEYPHRASE-NOTYPES 709 733	Garin-Bujadoux-Bannwarth
T22	KEYPHRASE-NOTYPES 734 744	syndrome
T23	KEYPHRASE-NOTYPES 750 762	Facial palsy
T24	KEYPHRASE-NOTYPES 766 778	Lyme disease
T25	KEYPHRASE-NOTYPES 806 827	peripheral neuropathy
T26	KEYPHRASE-NOTYPES 843 851	patients
T27	KEYPHRASE-NOTYPES 857 874	CSF abnormalities
T28	KEYPHRASE-NOTYPES 880 903	lymphocytic pleocytosis
T29	KEYPHRASE-NOTYPES 921 927	number
T30	KEYPHRASE-NOTYPES 931 943	plasma cells
T31	KEYPHRASE-NOTYPES 955 981	CSF protein concentrations
T32	KEYPHRASE-NOTYPES 993 1017	blood-CSF barrier damage
T33	KEYPHRASE-NOTYPES 1019 1044	intrathecal Ig production
T34	KEYPHRASE-NOTYPES 1060 1066	levels
T35	KEYPHRASE-NOTYPES 1072 1096	CSF glial protein marker
T36	KEYPHRASE-NOTYPES 1098 1129	glial fibrillary acidic protein
T37	KEYPHRASE-NOTYPES 1143 1151	findings
T38	KEYPHRASE-NOTYPES 1167 1183	brain parenchyma
T39	KEYPHRASE-NOTYPES 1217 1244	early Lyme neuroborreliosis
